Position in AZN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$157,005
New position
Shares Held
828
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,210
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $25,670,962 across 14 Drug Manufacturers - General names. AZN ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,882 | $10,636,771 | |
| 2 | LLY |
ELI LILLY & Co
|
5,815 | $6,974,686 | |
| 3 | ABBV |
AbbVie Inc.
|
26,493 | $6,666,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,825 | $491,512 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,594 | $201,385 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,450 | $198,789 | |
| 7 | AMGN |
Amgen Inc
|
499 | $180,697 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
828 | $157,005 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,005 | 828 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||